0001209191-18-005377.txt : 20180125
0001209191-18-005377.hdr.sgml : 20180125
20180125162646
ACCESSION NUMBER: 0001209191-18-005377
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180123
FILED AS OF DATE: 20180125
DATE AS OF CHANGE: 20180125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Danziger Asaf
CENTRAL INDEX KEY: 0001654435
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 18548544
MAIL ADDRESS:
STREET 1: 5 NACHUM CHAT ST.
CITY: TIRAT HACARMEL
STATE: L3
ZIP: 5112302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Novocure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4YE
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4YE
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-23
0
0001645113
Novocure Ltd
NVCR
0001654435
Danziger Asaf
C/O NOVOCURE INC.
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
1
1
0
0
Chief Executive Officer
Ordinary Shares
2018-01-23
4
S
0
10248
22.033
D
387820
D
Ordinary Shares
2018-01-24
4
S
0
10600
22.1705
D
377220
D
On January 23, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 10,248 shares in multiple trades at prices ranging from $22.00 to $22.15. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On January 24, 2018, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 10,600 shares in multiple trades at prices ranging from $22.00 to $22.45. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
By: /s/ Todd Longsworth, Attorney in fact for Asaf Danziger
2018-01-25